493800 Sigma-AldrichPARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem
The PARP Inhibitor VI, NU1025, also referenced under CAS 90417-38-2, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications.
More>> The PARP Inhibitor VI, NU1025, also referenced under CAS 90417-38-2, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications. Less<<同義語: 8-Hydroxy-2-methylquinazoline-4-one
お勧めの製品
概要
Replacement Information |
---|
主要スペック表
CAS # | Empirical Formula |
---|---|
90417-38-2 | C₉H₈N₂O₂ |
価格&在庫状況
カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
---|---|---|---|---|---|---|
493800-5MGCN |
|
樹脂アンプル | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 90417-38-2 |
ATP Competitive | N |
Form | Off-white solid |
Hill Formula | C₉H₈N₂O₂ |
Chemical formula | C₉H₈N₂O₂ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | PARP |
Primary Target IC<sub>50</sub> | 0.4 µM against poly(ADP-ribose) polymerase (PARP) |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
カタログ番号 | GTIN |
493800-5MGCN | 04055977272826 |
Documentation
PARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem (M)SDS
タイトル |
---|
PARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem 試験成績書(CoA)
タイトル | ロット番号 |
---|---|
493800 |
参考資料
参考資料の概要 |
---|
Delaney, C.A., et al. 2000. Clin. Cancer Res. 6, 2860. Boulton, S., et al. 1999. Carcinogenesis 20, 199. Bowman, K.J., et al. 1998. Br. J. Cancer 78, 1269. Griffin, R.J., et al. 1998. J. Med. Chem. 41, 5247. Griffin, R.J., et al. 1996. Pharm. Sci. 2, 43. Boulton, S., et al. 1995. Br. J. Cancer 72, 849. Griffin, R.J., et al. 1995. Anticancer Drug Res. 10, 507. |